DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
METERGOLINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
METERGOLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
1501393LY5
Molecule Type:
Small molecule
Molecular Formula:
C25H29N3O2
Molecular Weight:
403.53
AlogP:
4.06
PSA:
46.5
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IODOFORM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
IODOFORM
×
Maximum Phase:
4
First Approval:
None
UNII:
KXI2J76489
Molecule Type:
Small molecule
Molecular Formula:
CHI3
Molecular Weight:
393.73
AlogP:
2.58
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
EZETIMIBE; SIMVASTATIN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EZETIMIBE; SIMVASTATIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NIALAMIDE
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder
Monoamine oxidase inhibitor
NIALAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
T2Q0RYM725
Molecule Type:
Small molecule
Molecular Formula:
C16H18N4O2
Molecular Weight:
298.35
AlogP:
1.02
PSA:
83.12
HBD:
3.0
HBA:
#RotB:
7.0
Source:
TECHNETIUM TC-99M MEDRONATE
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M MEDRONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEROPENEM; VABORBACTAM
4
Combination
Approved
Unknown
INTRAVENOUS
Unknown
Unknown
MEROPENEM; VABORBACTAM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EBASTINE
4
Small molecule
Approved
Unknown
Unknown
Hypersensitivity
Histamine H1 receptor inverse agonist
EBASTINE
×
Maximum Phase:
4
First Approval:
None
UNII:
TQD7Q784P1
Molecule Type:
Small molecule
Molecular Formula:
C32H39NO2
Molecular Weight:
469.67
AlogP:
7.22
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
9.0
Source:
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; INTRINSIC FACTOR
4
Combination
Approved
OTHER
N/A
Unknown
Unknown
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; INTRINSIC FACTOR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYSTINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CYSTINE
×
Maximum Phase:
4
First Approval:
None
UNII:
48TCX9A1VT
Molecule Type:
Small molecule
Molecular Formula:
C6H12N2O4S2
Molecular Weight:
240.31
AlogP:
-0.81
PSA:
126.64
HBD:
4.0
HBA:
#RotB:
7.0
Source:
DEXTRANOMER
4
Small molecule
Approved
Unknown
Unknown
Skin Ulcer
Unknown
DEXTRANOMER
×
Maximum Phase:
4
First Approval:
None
UNII:
30KXI0TVD3
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIPULEUCEL-T
4
Cell
Unknown
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Prostatic acid phosphatase binding agent
SIPULEUCEL-T
×
Maximum Phase:
4
First Approval:
None
UNII:
8Q622VDR18
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GRISEOFULVIN, ULTRAMICROSIZE
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
GRISEOFULVIN, ULTRAMICROSIZE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALBUMIN, AGGREGATED
4
Protein
Approved
Unknown
Unknown
Unknown
Unknown
ALBUMIN, AGGREGATED
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHOLINE ALFOSCERATE
4
Small molecule
Approved
Unknown
Unknown
Cognitive Dysfunction; Diabetes Mellitus, Type 2
Unknown
CHOLINE ALFOSCERATE
×
Maximum Phase:
4
First Approval:
None
UNII:
60M22SGW66
Molecule Type:
Small molecule
Molecular Formula:
C8H20NO6P
Molecular Weight:
257.22
AlogP:
-1.45
PSA:
99.05
HBD:
2.0
HBA:
#RotB:
8.0
Source:
SODIUM FLUORIDE; TRICLOSAN
4
Combination
Approved
OTHER
DENTAL
Unknown
Unknown
SODIUM FLUORIDE; TRICLOSAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM CHROMATE CR 51
4
Small molecule
Approved
Unknown
Unknown
Unknown
Radiopharmaceutical
SODIUM CHROMATE CR 51
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
CrNa2O4
Molecular Weight:
160.92
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TECHNETIUM TC 99M SULFUR COLLOID
4
Unknown
Approved
Unknown
Unknown
Cystic Fibrosis; Breast Neoplasms; Melanoma; Neoplasms
Diagnostic agent
TECHNETIUM TC 99M SULFUR COLLOID
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALPHANATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ALPHANATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROSE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATROPINE SULFATE; EDROPHONIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ATROPINE SULFATE; EDROPHONIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IPRINDOLE
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder
Unknown
IPRINDOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
69U0IKR8FP
Molecule Type:
Small molecule
Molecular Formula:
C19H28N2
Molecular Weight:
284.45
AlogP:
4.25
PSA:
8.17
HBD:
0.0
HBA:
#RotB:
4.0
Source:
IODINE POVACRYLEX; ISOPROPYL ALCOHOL
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
IODINE POVACRYLEX; ISOPROPYL ALCOHOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACTIVATED PROTEIN C
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ACTIVATED PROTEIN C
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIPENZOLATE BROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PIPENZOLATE BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
JPX41DUS2B
Molecule Type:
Small molecule
Molecular Formula:
C22H28BrNO3
Molecular Weight:
434.37
AlogP:
3.09
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BERBERINE
4
Small molecule
Approved
Unknown
Unknown
Adenocarcinoma of Lung; Adenoma; Hyperlipidemia, Familial Combined; Non-alcoholic Fatty Liver Disease; Prediabetic State; Diabetes Mellitus, Type 2
Unknown
BERBERINE
×
Maximum Phase:
4
First Approval:
None
UNII:
0I8Y3P32UF
Molecule Type:
Small molecule
Molecular Formula:
C20H18NO4+
Molecular Weight:
336.37
AlogP:
3.1
PSA:
40.8
HBD:
0.0
HBA:
#RotB:
2.0
Source:
FENTICONAZOLE NITRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FENTICONAZOLE NITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
8V4JGC8YRF
Molecule Type:
Small molecule
Molecular Formula:
C24H21Cl2N3O4S
Molecular Weight:
518.42
AlogP:
7.3
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
8.0
Source:
ENALAPRIL MALEATE; FELODIPINE
4
Combination
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Unknown
Unknown
ENALAPRIL MALEATE; FELODIPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BRIMONIDINE TARTRATE; BRINZOLAMIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
BRIMONIDINE TARTRATE; BRINZOLAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMOBARBITAL SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
AMOBARBITAL SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
G0313KNC7D
Molecule Type:
Small molecule
Molecular Formula:
C11H17N2NaO3
Molecular Weight:
248.26
AlogP:
1.39
PSA:
78.76
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM
4
Small molecule
Approved
CANCER
INJECTION
Unknown
Unknown
SAMARIUM SM-153 LEXIDRONAM PENTASODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESOMEPRAZOLE MAGNESIUM;NAPROXEN
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ESOMEPRAZOLE MAGNESIUM;NAPROXEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ART-123
4
Protein
Approved
Unknown
Unknown
Unknown
Unknown
ART-123
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DROSPIRENONE; ESTRADIOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DROSPIRENONE; ESTRADIOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
285
286
287
288
289
290
291
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA